Corbus Pharmaceuticals Holdings, Inc. (CRBP): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$17.89M
As of 2023-12-31
-5.5%
3-year compound annual growth
$21.59M2020-12-31: $21.19M2021-12-31: $21.19M2022-12-31: $21.59M2023-12-31: $17.89M$17.89M
2020-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$17.89M-17.1%2024-03-12, Balance as of period end
2022-12-31$21.59M+1.9%2023-03-07, Balance as of period end
2021-12-31$21.19M0.0%2022-03-08, Balance as of period end
2020-12-31$21.19Mn/a2021-03-15, Balance as of period end